Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis (Q37330136)

19 August 2017

0 references

Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis (English)

1 reference

19 August 2017

0 references

anti-retroviral agent

0 references

0 references

Francisco I Bastos

4

0 references

Steffanie Strathdee

object named as

Steffanie A Strathdee

series ordinal

3

0 references

Monica Malta

series ordinal

1

object named as

Monica Malta

1 reference

19 August 2017

Monica M F Magnanini

2

1 reference

19 August 2017

20 November 2008

1 reference

19 August 2017

1 reference

19 August 2017

14

1 reference

19 August 2017

731-747

1 reference

19 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s10461-008-9489-7

19 August 2017

0 references

cites work

Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5").

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

Trust and the acceptance of and adherence to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

Illicit drug use and HIV treatment outcomes in a US cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

Routes of drug administration, differential affiliation, and lifestyle stability among cocaine and opiate users: implications to HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

Factors predicting lack of adherence to highly active antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

Access to highly active antiretroviral therapy for injection drug users: adherence, resistance, and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

Determinants of HAART discontinuation among injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10461-008-9489-7

10.1007/S10461-008-9489-7

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

19020970